I’d check out the Rolls-Royce share price as the FTSE 100 surges on Pfizer vaccine hopes

The Rolls-Royce share price has flown since news of the coronavirus vaccine emerged, and its long-term outlook now looks brighter.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

What a difference a day has made to the Rolls-Royce (LSE: RR) share price. Yesterday, it jumped an incredible 43.76%, driven by independent trial results showing the Pfizer and BioNTech vaccine could have a 90% effectiveness rate.

Anybody who took a chance on the Rolls-Royce share price in recent weeks will be celebrating right now. Others will be wondering whether there’s still an opportunity to hop on board.

Here at the Fool, we constantly urge readers to buy shares after a stock market crash, because that’s when investors can pick up top companies at bargain prices. But we don’t urge indiscriminate buying, because there’s often a very good reason for a company’s share price to crash.

Covid vaccine drives FTSE 100

The outlook for Rolls-Royce is undoubtedly tough, hence its share price problems. The FTSE 100 aircraft engine maker has been hit hard by the flying ban, as it makes its money from servicing contracts, based on miles flown.

The Rolls-Royce share price crashed from 229p at the start of the year to just 40p in early October, but has now taken off. Today, it trades at 114p. The question is, where does it go next?

Shares in Rolls-Royce continue to climb today, up another 14.15% this morning. The implications of a successful vaccine are sinking in, and investors are hunting for ways to play the post-Covid recovery pencilled in for next year.

As always, investors are buying the future. Today saw horrible news on redundancies, which hit a record high of 314,000 in the three months to September, while unemployment rose from 4.1% to 4.8%. They’re looking beyond that dismal tally, towards a brighter 2021.

I’d buy into the Rolls-Royce share price recovery

When the vaccine starts rolling out, and life returns to normal (or something like it), the airline industry will be a prime beneficiary. We saw how people rushed to book holidays during the summer. If so, the Rolls-Royce share price could have further to fly.

There are dangers, of course. This vaccine had better live up to its early results. Also, I’m wary of chasing a share price just after it’s jumped like Rolls-Royce just has. This week’s surge has partly been driven by short sellers covering their positions. It may fall back as others bank profits.

Rolls-Royce share price performance may also depend on the fate of the ‘Biden Bounce’, and whether his administration prioritises a UK trade. Chief executive Warren East previously warned of the impact of Brexit disruption, and the group has faced problems with its Trent 1000 engine.

I would buy Rolls-Royce for the long-term share price and dividend growth. I wouldn’t buy it to make a quick profit, that moment has passed. The future will remain bumpy. Even if the vaccine lives up to expectations, there’ll be plenty of economic after-shocks. Rolls-Royce remains a great British company though, and one I want to hold.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

This way, That way, The other way - pointing in different directions
Investing For Beginners

1 FTSE 250 stock I like and 1 I’ll avoid after the stock market correction

Jon Smith analyses the move lower in certain FTSE 250 companies over the past month and picks one that looks…

Read more »

Playful senior couple in aprons dancing and smiling while preparing healthy dinner at home
Investing Articles

Is April 2026 a great time to buy Lloyds shares?

Lloyds shares have been flying over the last two years. And there's one factor that could mean the bank continues…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Want to aim for a £500 second income each month? Here’s how much it takes

Christopher Ruane digs into the numbers and mechanics that could let someone with no shares today build an annual second…

Read more »

Aston Martin DBX - rear pic of trunk
Investing Articles

Down 95%, what might it take for the Aston Martin share price to rise 2,000%?

The Aston Martin share price has collapsed. Our writer considers what it might take for it to regain some ground…

Read more »

Investing Articles

How are Diageo shares looking in April 2026?

It's been an eventful year so far, but what has the impact been for Diageo shares, and where might they…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

P/Es below 7! 3 staggeringly cheap shares despite yesterday’s rally

Investors who fear they have missed their opportunity to buy cheap shares as the stock market recovers might want to…

Read more »

ISA coins
Investing Articles

Want to know what UK investors have been buying in their ISAs?

Looking for stock, trust, and fund ideas this April? Royston Wild discusses what Brits have been stuffing in their Stocks…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

Why aren’t people buying Greggs shares by the bucketload?

Greggs' shares remain in the doldrums. But should Foolish investors consider pouncing while others won't? Paul Summers takes a fresh…

Read more »